Pfizer had Twitter censor users tweeting at them to ask for generic low cost vaccines, per Lee Fang of Twitter Files

BioNTech, which developed Pfizer's, PFE, vaccine, reportedly reached out to Twitter to request that Twitter directly censor users tweeting at them to ask for generic low cost vaccines, per Lee Fang of Twitter Files.

Reportedly, BioNTech emaile Twitter directly to ask content moderators to censor users who had posted tweets asking the company to share its intellectual property.

Lobbyists worked directly for PFE.

“The authorities are warning about “serious consequences” of the action, i.e. posts and a flood of comments “that may violate [Twitter's terms of service]” as well as the “takeover of user accounts” are to be expected,” the lobbyist warned.

One of those posts was a tweet by a 74-year-old retired bricklayer in Britain warning that “people in poor countries are going to MISS OUT on a #COVID19 vaccine next year.”

“Several Twitter employees noted in subsequent messages that none of this activism constituted abuse,” Lee Fang said. “But the company continued monitoring tweets.”

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.